December 2025: Investment and Finance Issue

As the supplement industry navigates unprecedented economic turbulence—from tariff volatility and supply chain disruption to the MAHA movement's regulatory uncertainty—the investment landscape is undergoing a fundamental recalibration. In this issue, NBJ delivers an unflinching analysis of how M&A activity, private equity strategies, and capital allocation are evolving in response to shifting consumer priorities, strategic acquirer behavior, and macroeconomic headwinds. From the late-cycle dynamics driving mega-deals and divestitures among CPG giants to the rise of private equity-backed platforms filling the strategic void, this issue provides data-rich insights into where capital is flowing—and why. Featuring expert perspectives on tariff impact assessments, supply chain due diligence protocols, and the investment thesis behind clean label supplements, GLP-1 adjacencies, and longevity-focused brands, the Investment and Finance issue equips stakeholders to identify opportunities, mitigate risks, and position portfolios for resilience and growth through 2026's continued uncertainty.

Who it's for: Private equity investors, strategic acquirers, M&A advisors, brand founders seeking capital, and financial executives navigating deal-making, valuation strategies, and investment decisions in the health and wellness sector.

What they'll learn: How tariffs, regulatory uncertainty, and evolving strategic priorities are reshaping M&A valuations and deal structures—plus where investors are placing bets on supplement innovation, what due diligence now demands, and how to capitalize on emerging opportunities in a risk-averse, late-cycle market environment.